ArticleCureus2025
Amelanotic Nodular Melanoma Over the Knee Region: A Case Report of a Diagnostic Challenge From the United Arab Emirates.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amelanotic melanoma (AM) is a rare and aggressive subtype of cutaneous melanoma that lacks the characteristic pigmentation, which makes it challenging to diagnose, often resulting in delayed treatment. Nodular melanoma (NM), a subtype of AM, is associated with a poorer prognosis and is infrequently reported in the Middle East and North Africa (MENA) region. AM is a rare and aggressive subtype of cutaneous melanoma, accounting for approximately 1-8% of all melanoma cases. We present the case of a 39-year-old Filipino female with a slowly enlarging, skin-colored lesion on her right patella, initially misdiagnosed as a dermatofibroma. The lesion was later confirmed as type IIIb cutaneous amelanotic nodular melanoma via histopathology and immunohistochemistry, with a Breslow thickness of 5 mm and Clark level IV invasion. Sentinel lymph node biopsy revealed nodal involvement, and the patient underwent wide local excision followed by adjuvant immunotherapy. This report highlights the diagnostic challenges posed by AM, particularly in younger patients and in regions where such cases are rarely reported. Accurate diagnosis requires a high index of suspicion and a multimodal diagnostic approach. Early recognition and intervention are crucial for improving patient outcomes in this aggressive malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.